PRESS RELEASE published on 06/06/2023 at 16:25, 1 year 5 months ago Convatec Group PLC: Director/PDMR Shareholding*
PRESS RELEASE published on 05/31/2023 at 11:06, 1 year 5 months ago Convatec Group PLC: Total Voting Rights
PRESS RELEASE published on 05/18/2023 at 17:15, 1 year 6 months ago Convatec Group PLC: Result of AGM
PRESS RELEASE published on 05/17/2023 at 13:30, 1 year 6 months ago Convatec Group PLC: TR1 - Notification of Major Holdings
PRESS RELEASE published on 05/09/2023 at 16:15, 1 year 6 months ago Convatec Group PLC: Scrip Dividend - Total Issued Shares
PRESS RELEASE published on 05/03/2023 at 15:10, 1 year 6 months ago Convatec Group PLC: Director/PDMR Shareholding
PRESS RELEASE published on 04/26/2023 at 14:48, 1 year 6 months ago Convatec Group PLC: HOL-Holding(s) in Company
PRESS RELEASE published on 04/17/2023 at 17:55, 1 year 7 months ago Convatec Group PLC: Scrip Dividend - Calculation Price
PRESS RELEASE published on 03/22/2023 at 12:00, 1 year 7 months ago Convatec Group PLC: Annual Report and Accounts 2022 and Notice of AGM
PRESS RELEASE published on 03/17/2023 at 11:30, 1 year 8 months ago Convatec Group PLC: Director/PDMR Shareholding
Published on 11/21/2024 at 13:00, 29 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 29 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 29 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 29 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 29 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 54 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 14 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 31 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 9 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 44 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 44 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo